KRAIG BIOCRAFT LABORATORIES, INC Financials

Copyright © 2009 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service - Copyright/IP Policy - Send Feedback Quotes delayed, except where indicated otherwise.Delay times are 15 mins for NASDAQ, 20 mins for NYSE and Amex. See also delay times for other exchanges.Fundamental company data provided by Capital IQ. Quotes and other information supplied by independent providers identified on the Yahoo! Finance partner page. Quotes are updated automatically, but will be turned off after 25 minutes of inactivity. Quotes are delayed at least 15 minutes. Real-...
Click here to read the whole Article (external link)

KRAIG BIOCRAFT LABORATORIES, INC Files SEC form 10-Q, Quarterly Report

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Caution Regarding Forward-Looking Information Certain statements contained herein, including, without limitation, statements containing the words "believes", "anticipates", "expects" and words of similar import, constitute forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following: international, national and local general economic and market conditions: demographic changes; the ability of the Company to sustain, manage or forecast its growth; the ability of the Company to successfully make and integrate acquisitions; raw material costs and availability; new product development and introduction; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; the ability to protect technology; and other factors referenced in this and previous filings. Given these uncertainties, readers of this prospectus and investors are cautioned not to place undue reliance on such forward-looking statements. Plan of Operations During the next twelve months, we expect to take the following steps in connection with the further development of our business and the implementation of our plan of operations: » We expect to spend up to $35,000 per quarter through March 2010 on collabora...
Click here to read the whole Article (external link)

SectorWatch.biz: The Super-Fiber Revolution

IRVINE, Calif., June 25, 2009 (GLOBE NEWSWIRE) -- SectorWatch.biz announces the availability of an important new commentary of interest to investors in Kraig Biocraft Laboratories, Inc. (OTCBB:KBLB - News) and other high-performance fiber equities making news and driving markets today. Investors can view our free commentaries at: www.SectorWatch.biz -- in association with FiSpace.net, a dynamic social networking site for investors. For decades scientists have been fascinated by the silk fibers that make up certain spider webs. In fact, spider silk is one of the strongest and most resilient fibers known to man, making it a potential "super fiber" for a host of ballistic resistant, medical, and industrial applications. We are told that spider silk is about five times stronger than steel and twice as strong as DuPont's market-leading Kevlar(r) on a pound-for-pound basis. Spider silk can also stretch about 30% longer than its original length without breaking, making its threads extremely resilient. Kraig Biocraft Laboratories is developing a way of inserting spider silk DNA directly into silkworms allowing silkworms to produce the proteins for spider silk. Kraig is working in cooperation with University of Notre Dame scientists and laboratories to create new polymers with potentially broad applications for consumers ...
Click here to read the whole Article (external link)

SectorWatch.biz: Paving the Way for Spider Silk

IRVINE, Calif., June 16, 2009 (GLOBE NEWSWIRE) -- SectorWatch.biz announces the availability of a commentary of interest to investors in Kraig Biocraft Laboratories, Inc. (OTCBB:KBLB - News) and other high-performance fiber equities making news and driving markets today. Investors can view our free commentaries at: www.SectorWatch.biz - in association with FiSpace.net, a dynamic social networking site for investors. The allure of silk dates back many centuries likely because of silk's unique properties. The lowly silkworm, cultivated in China over 5,000 years ago, is commonly associated with silk production. But the silkworm isn't the only source of natural silk. In fact, spider silk is said to be one of the strongest natural fibers and actually has superior tensile strength and energy absorption properties. But an effective production methodology has eluded science . perhaps until now. Enter Kraig Biocraft Laboratories, which is developing a way of inserting spider silk DNA directly into silkworms allowing the silkworms to produce the proteins for spider silk. This genetically-engineered spider silk could conceivably dominate the high performance fiber market, a market potentially worth billions. A report titled "The New Silk Road" is available FREE at this link: ...
Click here to read the whole Article (external link)

Kraig Biocraft Laboratories, Inc. Issues Stock Dividend

LANSING, Mich., May 29, 2009 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCBB:KBLB - News) is pleased to announce that it has successfully issued its stock dividend. "The issuance of the dividend has been in the planning for some time and has been an important part of the Company's plan for returning value to our shareholders. Just as important, we believe that the issuance has laid the groundwork for the Company's long term future," said CEO Kim K Thompson. "The input we have received from our shareholders throughout this process has been and continues to be overwhelmingly positive. We are also very excited about the progress in the laboratory and are very hopeful that the scientific team can maintain their tremendous forward momentum through the summer and fall and into 2010." Kraig is working to develop and commercialize high performance polymers using spider silk gene sequences. The company plans to tap into the $92 billion market for high performance and technical fibers. In 2007 Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame. Since that time the Company has been a proud sponsor of scientific research and development within the university. For more information on Kraig Biocraft Laboratories, and to hear an audio interview with Kraig's CEO, please visit the Company's web site: ...
Click here to read the whole Article (external link)

KRAIG BIOCRAFT LABORATORIES, INC Files SEC form 10-Q, Quarterly Report

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Caution Regarding Forward-Looking Information Certain statements contained herein, including, without limitation, statements containing the words "believes", "anticipates", "expects" and words of similar import, constitute forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following: international, national and local general economic and market conditions: demographic changes; the ability of the Company to sustain, manage or forecast its growth; the ability of the Company to successfully make and integrate acquisitions; raw material costs and availability; new product development and introduction; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; the ability to protect technology; and other factors referenced in this and previous filings. Given these uncertainties, readers of this prospectus and investors are cautioned not to place undue reliance on such forward-looking statements. Plan of Operations During the next twelve months, we expect to take the following steps in connection with the further development of our business and the implementation of our plan of operations: » We expect to spend up to $35,000 per quarter through March 2010 on collabor...
Click here to read the whole Article (external link)

Kraig Biocraft Laboratories, Inc. Gears Up to Double the Number of Genetic Insertions Performed

LANSING, Mich., May 12, 2009 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCBB:KBLB - News) announce that the scientific team is preparing to significantly ramp up the number of genetic insertions performed in the month of May. The team anticipates that the rate of DNA construct insertions in May will be double that which has been performed to date. "We are now entering the next phase in which the team is reallocating recourses to genetic insertion," said CEO Kim Thompson. "This is directly related to our recent development of new DNA constructs that are specifically targeted for the production of new fusion silk proteins. We intend to dramatically ramp up the number of insertions performed in order to gain the maximum benefit from the new insertion packets." Every targeted DNA packet insertion has the potential to create a new recombinant fiber with commercial applications. Kraig is working to develop and commercialize high performance polymers using spider silk gene sequences. The company plans to tap into the $92 billion market for high performance and technical fibers. In 2007 Kraig Biocraft Laboratories signed an intellectual property and collaborative research agreement with the University of Notre Dame. Since that time the Company has been a proud sponsor of scientific research and development within the university. For more information on Kraig Biocraft Laboratories, and to hear an audio interview with Kraig's CEO, please visit the Company's web site: ...
Click here to read the whole Article (external link)

Kraig Biocraft Laboratories, Inc. Successfully Creates Genetic Constructs for Several Unique Fusion Silk Proteins

LANSING, Mich., May 4, 2009 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCBB:KBLB - News) is pleased to announce that Dr. Malcolm Fraser, working in cooperation with Dr. Wang, Dr. Sohn and other members of the scientific team, has recently succeeded in building eight unique DNA constructs which the team is preparing for genetic insertion over the next several weeks. These genetic insertion packets include several that are specifically targeted for the production of new fusion silk proteins. "These constructs include a number of new DNA combinations that are truly exciting," said CEO Kim K. Thompson. "The increases in laboratory productivity over the last eight months are now enabling us to do more and to do it faster. This number of unique genetic constructs is a new breakthrough for the Company. Each of these constructs has the potential to result in the development of a new polymer or high performance fiber." The genetic constructs are customized packets of DNA which provide genetic instructions for the creation of new polymers and spider silk-based proteins. Over the last year, the University of Notre Dame added Dr. Wang, Dr. Sohn and other scientists to the research team. "Since that time, we have seen a dramatic increase in both the quality and quantity of the work performed," said Thompson. "We are ready to ramp up our effort to insert as many constructs as possible," added Dr. Fraser. Kraig is working to develop and commercialize high performance polymers using spider silk gene sequences. T...
Click here to read the whole Article (external link)

KRAIG BIOCRAFT LABORATORIES, INC Files SEC form 10-K, Annual Report

ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. Caution Regarding Forward-Looking Information Certain statements contained herein, including, without limitation, statements containing the words "believes", "anticipates", "expects" and words of similar import, constitute forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, among others, the following: international, national and local general economic and market conditions: demographic changes; the ability of the Company to sustain, manage or forecast its growth; the ability of the Company to successfully make and integrate acquisitions; raw material costs and availability; new product development and introduction; existing government regulations and changes in, or the failure to comply with, government regulations; adverse publicity; competition; the loss of significant customers or suppliers; fluctuations and difficulty in forecasting operating results; changes in business strategy or development plans; business disruptions; the ability to attract and retain qualified personnel; the ability to protect technology; and other factors referenced in this and previous filings. Given these uncertainties, readers of this prospectus and investors are cautioned not to place undue reliance on such forward-looking statements. Plan of Operations During the next twelve months, we expect to take the following steps in connection with the further development of our business and the implementation of our plan of operations: » We expect to spend up to $35,000 per quarter through March 2009 o...
Click here to read the whole Article (external link)

Kraig Biocraft Laboratories, Inc. Declares April 27 Record Date for Stock Dividend

LANSING, Mich., April 15, 2009 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTC BB:KBLB.OB - News) has declared a stock dividend. All shareholders of record as of the close of business on the record date will be issued nine additional shares for each share of common stock held. The record date is April 27, 2009. ``This stock dividend is intended to lay the groundwork for the growth of the Company,'' said CEO Kim K. Thompson. ``It is part of our ongoing efforts to promote capital investment, broaden ownership, improve trading liquidity, and enhance shareholder value. This action is enabled by the Company's continued success in the laboratory and is consistent with the Board's commitment to take actions designed to increase capital investment and create a wider distribution of the Company's stock.''The declaration of the stock dividend follows the announcement over the last several months of significant increases in laboratory productivity. The Company believes these dramatic increases in productivity are the direct result of the Company's successful efforts to recruit highly talented scientists and researchers in 2008. ``Ultimate credit for the increased pace of work in the laboratory belongs to Dr. Fraser and the University of Notre Dame research team,'' said Kim Thompson.Kraig is a biotechnology company developing advanced materials and high performance polymers. The Company believes that these materials have the potential to make a significant impact on the $92 billion market for high performance and technica...
Click here to read the whole Article (external link)